Arnatar Therapeutics
Arnatar Therapeutics develops RNA medicines from a platform it calls DARGER; which pairs highly active siRNA for silencing a gene with ACT-UP1; an antisense technology that does the opposite and incre
Funding history
About Arnatar Therapeutics
How much funding has Arnatar Therapeutics raised?
Arnatar Therapeutics has raised $52.0M in total funding. The most recent round was Series A.
Where is Arnatar Therapeutics headquartered?
Arnatar Therapeutics is headquartered in San Diego, CA.
What does Arnatar Therapeutics do?
Arnatar Therapeutics develops RNA medicines from a platform it calls DARGER; which pairs highly active siRNA for silencing a gene with ACT-UP1; an antisense technology that does the opposite and incre
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 9, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.